化学療法誘発性末梢神経障害市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00028941
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 151
Buy Now

[調査レポート] 化学療法による末梢神経障害市場は、2021 年の 8 億 1,348 万ドルから 2028 年には 11 億 7,426 万ドルに達すると予測されています。 2021 年から 2028 年にかけて 5.4% の CAGR を記録すると予想されます。



化学療法による末梢神経障害は、抗腫瘍薬によって引き起こされる最も頻繁な副作用の 1 つです。臨床的には、さまざまな強度と期間の運動および自律神経の変化を伴う可能性がある、主に感覚神経障害です。がん患者の有病率が高いため、化学療法誘発性末梢神経障害は、がん患者とサバイバーの両方、および医療提供者にとって大きな問題となっています。さらに、この症候群を治療する可能性は限られています。



戦略的洞察



このレポートは、化学療法誘発性末梢神経障害 (CIPN) 市場は、市場の動向、技術の進歩、および市場のダイナミクスを強調しています。また、世界中の主要な市場プレーヤーの競争状況分析も提供します。さらに、このレポートには、COVID-19 パンデミックがすべての地域の化学療法誘発性末梢神経障害市場に与える影響が含まれています。パンデミックは、世界中で公衆衛生の危機と経済危機の両方を引き起こしています。化学療法の世界市場は、がんのスクリーニング、相談、治療が定期的に行われるようになったため、パンデミックが絶えず拡大する前に、末梢神経障害を引き起こしました。 COVID-19 の第 1 波により、腫瘍症例の診察、フォローアップ、スクリーニングが中断されました。さらに、COVID-19 パンデミックの初期段階における臨床試験と患者への医薬品供給の混乱は、化学療法誘発性末梢神経障害市場の最も重要な分野に影響を与えました。 COVID-19 の迅速な治療に焦点が移ったことで、他のさまざまな病状に対する過失が生じました。さらに、癌症例の発見と治療のための化学療法セッションの減少は、化学療法誘発性末梢神経障害の診断と治療の需要を妨げました。



化学療法による末梢神経障害市場の有利な地域



市場の洞察



癌の有病率の増加化学療法誘発性末梢神経障害市場の成長を促進

がんは世界中で主要な死因です。世界保健機関 (WHO) によると、がんは 2019 年に世界 183 か国で 70 歳未満の人々の主要な死因の第 1 位であり、全年齢層の人口の中で第 4 位の主要な死因であると報告されています。さらに、2021 年 3 月に WHO が発表したデータによると、2020 年にはさまざまな種類のがんが原因で約 1,000 万人が死亡しています。



2020 年の世界で最も蔓延しているがんの形態

癌の有病率の増加は、化学療法の需要を高めるとともに、世界中の医療システムに負担をかけています。化学療法誘発性末梢神経障害は、プラチナ誘導体薬剤 (シスプラチンおよびオキサリプラチン)、紡錘体毒 [タキサン (パクリタキセルおよびドセタキセル)、ビンカ アルカロイド、ビンクリスチン、エポチロン、およびエリブリン]、ボルテゾミブ、そしてサリドマイド。化学療法誘発性末梢神経障害の有病率が高いことは、特にこの状態を予防する単一の効果的な方法がないため、がん患者と生存者、およびその医療従事者に懸念を引き起こします.



In a 「The Journal of the International Association for the Study of Pain」が実施した研究。化学療法による末梢神経障害の有病率は 68.1% (化学療法後最初の 1 か月で測定した場合は 57.7-78.4、3 か月目で 60.0% (36.4-81.6)、6 か月目以降で 30.0% (6.4-53.5)) と報告されました。 . したがって、癌の有病率の増加に伴う化学療法誘発性末梢神経障害の発生率の増加は、化学療法誘発性末梢神経障害市場の成長を後押しします.



薬物クラスベースの洞察

薬物クラスに基づいて、化学療法誘発性末梢神経障害市場は、ステロイド、抗うつ薬、抗てんかん薬、および麻薬に分割されます.2021 年には、ステロイド セグメントが市場で最大のシェアを占めました.抗てんかんセグメントは、予測期間中に 6.2% という最速の CAGR を記録すると予想されます。



化学療法による末梢神経障害市場、製品別 - 2020 年および 2028 年

< TIP>

流通チャネルベースの洞察



流通チャネルに基づいて、化学療法誘発性末梢神経障害市場は、病院薬局、小売薬局、およびオンライン薬局に分割されます。 2021 年には、病院の薬局セグメントが市場で最大のシェアを占めていました。さらに、小売薬局セグメントは、2021 年から 2028 年の間に 5.9% という最高の CAGR を報告すると予想されます。



化学療法誘発性末梢神経障害 (CIPN) 市場のプレーヤーは、次のような有機的戦略の採用に焦点を当てています。



地域別



地理に基づいて、化学療法誘発性末梢神経障害市場は、北米 (米国、カナダ、メキシコ)、ヨーロッパ (英国、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ)、アジア太平洋 (中国、日本、インド、オーストラリア、韓国、およびその他のアジア太平洋地域)、中東およびアフリカ (UAE、サウジアラビア、南アフリカ、およびその他の中東およびアフリカ)、および中南米 (ブラジル、アルゼンチン、およびその他の地域)



会社概要




  1. Regenacy Pharmaceuticals, Inc.
  2. < TIP>
  3. 旭化成ファーマ株式会社

  4. ノバレメド

  5. Makscientific, Llc

  6. Wex Pharmaceuticals Inc.
  7. >
  8. Sova Pharmaceuticals, Inc.

  9. Kineta, Inc.

  10. Aptinyx Inc.

  11. Apexian Pharmaceuticals, Inc.

  12. Winsantor, Inc.



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the chemotherapy induced peripheral neuropathy market?

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effects caused by antineoplastic agents. Clinically, CIPN is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes of varying intensity and duration. Due to its high prevalence among cancer patients, CIPN constitutes a major problem for both cancer patients and survivors as well as for their health care providers, especially because, at the moment, there is no single effective method of preventing CIPN; moreover, the possibilities of treating this syndrome are very limited.

What are the driving factors for the chemotherapy induced peripheral neuropathy market across the country?

The factors that are driving and restraining factors that will affect the chemotherapy induced peripheral neuropathy market in the coming years. Major factors driving the market growth include the increasing prevalence of cancer and increasing preference for chemotherapy. Additionally, the growing clinical trials for chemotherapeutic drugs is likely to emerge as a significant future trend in the market during the forecast period. However, lack of consolidated guidelines for chemotherapy hamper the chemotherapy induced peripheral neuropathy market growth.

Which segment is dominating the chemotherapy induced peripheral neuropathy market?

The chemotherapy induced peripheral neuropathy market, by drug class, is bifurcated into steroids, antidepressants, anti-seizure medicines, and narcotics. In 2021, the steroids segment held the largest share of the market. The anti-seizure medicines segment of the chemotherapy induced peripheral neuropathy market is expected to witness growth in its demand at the fastest CAGR during the forecast period.

Who are the major players in market the chemotherapy induced peripheral neuropathy market?

The chemotherapy induced peripheral neuropathy market majorly consists of the players such as Regenacy Pharmaceuticals, Inc, Asahi Kasei Pharma Corporation., Novaremed, Makscientific, Llc, Wex Pharmaceuticals Inc., Sova Pharmaceuticals, Inc., Kineta, Inc., Aptinyx Inc., Apexian Pharmaceuticals, Inc., and Winsantor, Inc. amongst others.

The List of Companies - Chemotherapy Induced Peripheral Neuropathy Market

  1. REGENACY PHARMACEUTICALS, INC
  2. ASAHI KASEI PHARMA CORPORATION
  3. NOVAREMED
  4. MAKSCIENTIFIC, LLC
  5. WEX PHARMACEUTICALS INC
  6. SOVA PHARMACEUTICALS, INC
  7. KINETA, INC.
  8. APTINYX INC.
  9. APEXIAN PHARMACEUTICALS, INC.
  10. WINSANTOR, INC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports